The latest version of Imagio features integration of ultrasound technology into the optoacoustic probe, a new ultrasound probe, and elimination of redundant electronics, according to the vendor. Using a combination of ultrasound and optoacoustic technology, Imagio is designed to aid physicians in differentiating malignant and benign breast masses in real time, Seno said.